Sat, 01/01/2011 - 12:23 by Jeff Fischer
For a long time, I've felt like the cat that caught the canary. Despite being a Fool since 1994, I've been using stock options this past decade and realized years ago what a strategic, useful, and profitable tool they can be -- even for a long-term stock investor.
Sat, 01/01/2011 - 11:02 by Rick Aristotle ...
The year is ending on an upbeat note. The Dow hit a two-year high this week, and most investors appear to believe that the economy will continue to improve in 2011. Well, not so fast.
Sat, 01/01/2011 - 10:54 by Anders Bylund
Attempts to lift Evergreen Solar (Nasdaq: ESLR) out of the penny-stock swamp by natural means aren't working. Here comes the reverse split! Evergreen will trade under the new symbol ESLRD for 20 days starting tomorrow (yes, the split happens on a Saturday). The market is taking this in stride as the plan was approved months ago and largely finalized this month. Monday morning, Evergreen's shares should be worth about $3 per share, reflecting a 1-for-6 reverse split.
Sat, 01/01/2011 - 10:41 by Brian Orelli
There's no way to sugarcoat this: It was not a pretty year for pharmaceutical companies. While the S&P saw substantial gains over the last year, with the exception of Bristol-Myers Squibb (NYSE: BMY) and Novartis (NYSE: NVS), every other major pharmaceutical company listed on the U.S. exchange saw their shares decrease. And neither of the two that were in positive territory actually surpassed the S&P 500.
Sat, 01/01/2011 - 10:14 by Brian D. Pacampara
Sat, 01/01/2011 - 07:44 by Tim Beyers
Each year, we take a look back in order to look ahead. We do this by industry, by trend, and ultimately by stock. Here's a closer look at Akamai Technologies(Nasdaq: AKAM), Fool style.
Sat, 01/01/2011 - 07:42 by Sean Williams
Running a 24-hour live chat for charity was a challenge of my endurance as well as my mind. Plenty of great companies were brought up in our discussion, especially a few that had somehow fallen off my radar.
Sat, 01/01/2011 - 07:05 by Andrew Bond
We recently learned that housing starts "beat" expectations in November, rising 3.9% over the previous month. I am not a housing expert, but I thought increasing supply in an already oversaturated market with depressed demand is a bad thing. However, a recent Bloomberg article discusses why more homebuilding is a positive for the economy as it would add a significant amount of jobs to the economy. While this may be true, I believe improvement would be offset by a continuing decline in home prices.
Fri, 31/12/2010 - 17:32 by Seth Jayson
Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.
Fri, 31/12/2010 - 17:29 by Anand Chokkavelu
Numbers can lie -- but they're the best first step in determining whether a stock is a buy. In this series, we use some carefully chosen metrics to size up a stock's true value based on the following clues: